Metraipolis › archive › dc_04cc64413a35

A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42801642
DOI
10.1002/advs.77992
License (as archived)
solo-consultazione
Archived
2026-10-07T20:45:54.915Z
SHA-256 of the archived text
37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a
Stable URL of this page
https://metraipolis.com/documento/dc_04cc64413a35

How to cite

A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642 — Europe PMC (en), https://europepmc.org/article/MED/42801642 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cc64413a35 (Metraipolis archive dc_04cc64413a35, sha256 37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a)
BibTeX
@misc{dc04cc64413a35,
  title = {A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42801642},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cc64413a35; sha256 37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42801642. Agents can read the archived copy with the MCP tool read_document.